Skip to main content

Medicare & Medicaid

By Susan Morse | 12:21 pm | March 02, 2023
The drugmaker, the Biden administration and organizations are calling on other companies to do the same.
By Jeff Lagasse | 12:12 pm | March 02, 2023
By the end of 2021, gross margins per enrollee had returned to pre-pandemic levels in the Medicare Advantage market.
By Jeff Lagasse | 08:59 am | March 02, 2023
CEO Andrew Toy says the company is achieving "real momentum" toward profitability, and has priced its insurance plans with that in mind.
By Jeff Lagasse | 04:33 pm | February 28, 2023
Apparent differences in potentially avoidable hospitalizations among MA plans may be explained by shifting inpatient care to other settings.
By Susan Morse | 11:38 am | February 28, 2023
For those with private insurance, coverage for telehealth and other remote care services will vary by plan after the end of the PHE.
By Susan Morse | 12:32 pm | February 23, 2023
CMS says it must examine whether a medication is reasonable and necessary while the FDA assesses whether medications are safe and effective. 
By Jeff Lagasse | 11:58 am | February 22, 2023
This year, Medicare Advantage enrollment grew by just 1.5 million, below the pace set in previous years.
By Jeff Lagasse | 01:19 pm | February 21, 2023
MA plans have adopted more restrictive criteria commonly used by commercial health insurance carriers, found consulting firm Crowe.
By Jeff Lagasse | 04:50 pm | February 20, 2023
Patients in such models were 18% less likely to be admitted to the hospital and had a 9% lower 30-day readmission rate.
By Jeff Lagasse | 01:32 pm | February 20, 2023
On April 1, states can begin disenrolling Medicaid enrollees for the first time since March 2020.